1. Home
  2. ORKT vs INM Comparison

ORKT vs INM Comparison

Compare ORKT & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORKT
  • INM
  • Stock Information
  • Founded
  • ORKT 2003
  • INM 1981
  • Country
  • ORKT Singapore
  • INM Canada
  • Employees
  • ORKT N/A
  • INM N/A
  • Industry
  • ORKT
  • INM Biotechnology: Pharmaceutical Preparations
  • Sector
  • ORKT
  • INM Health Care
  • Exchange
  • ORKT NYSE
  • INM Nasdaq
  • Market Cap
  • ORKT N/A
  • INM 3.2M
  • IPO Year
  • ORKT 2024
  • INM N/A
  • Fundamental
  • Price
  • ORKT $0.47
  • INM $2.30
  • Analyst Decision
  • ORKT Strong Buy
  • INM
  • Analyst Count
  • ORKT 1
  • INM 0
  • Target Price
  • ORKT $5.00
  • INM N/A
  • AVG Volume (30 Days)
  • ORKT 258.0K
  • INM 46.6K
  • Earning Date
  • ORKT 01-01-0001
  • INM 05-13-2025
  • Dividend Yield
  • ORKT N/A
  • INM N/A
  • EPS Growth
  • ORKT N/A
  • INM N/A
  • EPS
  • ORKT N/A
  • INM N/A
  • Revenue
  • ORKT $2,962,282.00
  • INM $4,832,013.00
  • Revenue This Year
  • ORKT $9.63
  • INM N/A
  • Revenue Next Year
  • ORKT N/A
  • INM N/A
  • P/E Ratio
  • ORKT N/A
  • INM N/A
  • Revenue Growth
  • ORKT N/A
  • INM N/A
  • 52 Week Low
  • ORKT $0.44
  • INM $1.72
  • 52 Week High
  • ORKT $8.00
  • INM $15.70
  • Technical
  • Relative Strength Index (RSI)
  • ORKT N/A
  • INM 34.09
  • Support Level
  • ORKT N/A
  • INM $2.70
  • Resistance Level
  • ORKT N/A
  • INM $3.20
  • Average True Range (ATR)
  • ORKT 0.00
  • INM 0.23
  • MACD
  • ORKT 0.00
  • INM -0.05
  • Stochastic Oscillator
  • ORKT 0.00
  • INM 5.26

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

Share on Social Networks: